Follow
Miguel Hernan
Miguel Hernan
Director, CAUSALab / Professor of Biostatistics and Epidemiology, Harvard T.H. Chan School
Verified email at hsph.harvard.edu - Homepage
Title
Cited by
Cited by
Year
RoB 2: a revised tool for assessing risk of bias in randomised trials
JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ...
bmj 366, 2019
142372019
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ...
bmj 355, 2016
110592016
Marginal structural models and causal inference in epidemiology
JM Robins, MA Hernan, B Brumback
Epidemiology 11 (5), 550-560, 2000
56442000
Causal inference
MA Hernán, JM Robins
CRC, 2010
36682010
A structural approach to selection bias
MA Hernán, S Hernández-Díaz, JM Robins
Epidemiology 15 (5), 615-625, 2004
28172004
Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts
R Estruch, E Ros, J Salas-Salvadó, MI Covas, D Corella, F Arós, ...
New England journal of medicine 378 (25), e34, 2018
27942018
BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting
N Dagan, N Barda, E Kepten, O Miron, S Perchik, MA Katz, MA Hernán, ...
New England Journal of Medicine 384 (15), 1412-1423, 2021
26562021
Constructing inverse probability weights for marginal structural models
SR Cole, MA Hernán
American journal of epidemiology 168 (6), 656-664, 2008
25632008
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
M Pollán, B Pérez-Gómez, R Pastor-Barriuso, J Oteo, MA Hernán, ...
The Lancet 396 (10250), 535-544, 2020
19992020
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MÁ Hernán, B Brumback, JM Robins
Epidemiology 11 (5), 561-570, 2000
18952000
Using big data to emulate a target trial when a randomized trial is not available
MA Hernán, JM Robins
American journal of epidemiology 183 (8), 758-764, 2016
16652016
Vitamin D intake and incidence of multiple sclerosis
KL Munger, SM Zhang, E O’reilly, MA Hernan, MJ Olek, WC Willett, ...
Neurology 62 (1), 60-65, 2004
15962004
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
HK Choi, MA Hernán, JD Seeger, JM Robins, F Wolfe
The Lancet 359 (9313), 1173-1177, 2002
15412002
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology
MA Hernán, S Hernández-Díaz, MM Werler, AA Mitchell
American journal of epidemiology 155 (2), 176-184, 2002
15032002
Estimating causal effects from epidemiological data
MA Hernán, JM Robins
Journal of Epidemiology & Community Health 60 (7), 578-586, 2006
11492006
The hazards of hazard ratios
MA Hernán
Epidemiology 21 (1), 13-15, 2010
11242010
Instruments for causal inference: an epidemiologist's dream?
MA Hernán, JM Robins
Epidemiology 17 (4), 360-372, 2006
11042006
Temporal trends in the incidence of multiple sclerosis: a systematic review
A Alonso, MA Hernán
Neurology 71 (2), 129-135, 2008
10882008
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
MA Hernán, B Takkouche, F Caamaño‐Isorna, JJ Gestal‐Otero
Annals of neurology 52 (3), 276-284, 2002
10642002
Activated injectable vitamin D and hemodialysis survival: a historical cohort study
M Teng, M Wolf, MN Ofsthun, JM Lazarus, MA Hernán, CA Camargo Jr, ...
Journal of the American Society of Nephrology 16 (4), 1115-1125, 2005
10352005
The system can't perform the operation now. Try again later.
Articles 1–20